Briaud Financial Planning’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Briaud Financial Planning's BMY Position: Q3 2025 in Review
Briaud Financial Planning sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 1,536 shares — an estimated $71K sold.
Briaud Financial Planning first reported a position in BMY in Q3 2023 and held it in 7 quarters. The position peaked at $93K in Q1 2025. 2,274 funds tracked by Wall St. Rank hold BMY as of Q3 2025.
- Briaud Financial Planning reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
- Briaud Financial Planning sold 1,536 Bristol-Myers Squibb shares in Q3 2025, an estimated $71K.
- Briaud Financial Planning first reported a position in Bristol-Myers Squibb in Q3 2023 and held it in 7 quarters.
- Briaud Financial Planning's Bristol-Myers Squibb position peaked at $93K in Q1 2025.
- 2,274 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.
Based on Briaud Financial Planning's 13F filing for Q3 2025, filed 25 Nov 2025.